Journal
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
Volume 19, Issue 5, Pages 893-900Publisher
IVYSPRING INT PUBL
DOI: 10.7150/ijms.73489
Keywords
Aqueous Humor; Age-related macular degeneration; Exosome
Categories
Funding
- National Core Facility for Biopharmaceuticals (NCFB), Ministry of Science and Technology
- Ministry of Science and Technology of Taiwan [MOST 108-2314-B-532-009-]
- Taipei City Hospital [TPCH-110-]
Ask authors/readers for more resources
This study examined the exosomal protein profile of patients with age-related macular degeneration (AMD) and found significant differences in the exosomal proteins between AMD patients and controls. The exosomal proteins in AMD patients were enriched in the lipoprotein metabolic process. Additionally, the study observed a decrease in the amount of two proteins in AMD patients receiving anti-VEGF therapy with longer treatment duration.
Purpose: The alteration of the exosomal proteins in the aqueous humor (AH) is linked to the development of eye diseases. The goal of this study was to examine the exosomal protein profile of patients with age-related macular degeneration (AMD) to better understand their role in the pathogenesis of AMD. Methods: Exosomes were isolated from the AH of 28 AMD and 25 control eyes. The quality, concentration, and size distribution of exosomes were measured using a nanoparticle tracking analysis system (NTA). Total exosomal proteins from each sample were purified and digested with trypsin for liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Results: Based on LC-MS/MS analysis, we got 105 exosomal peptides from AMD and control patients. Gene ontology (GO) analysis in the biology process revealed that exosomal proteins of AMD were enriched in the lipoprotein metabolic process. T-test analysis revealed six exosomal proteins in patients with AMD were significantly different from controls. Comparing the exosomal protein profile of AMD patients who were receiving anti-VEGF therapy, we observed the amount of two proteins decreased with the duration of the anti-VEGF treatment time. Conclusions: In this study, we successfully isolated and purified AH exosomes. Our results provide pioneering findings for the exosomal protein profile in AMD development and under therapy. These unique proteins could be the new targets for drug discovery or biological markers for evaluating therapeutic efficacy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available